Thiazolidinediones (TZDs), rosiglitazone and pioglitazone, have been shown to increase fracture risk in women after a year of TZD use; however, there has been little data available on the effects of the discontinuation of TZD. This longitudinal observational cohort study used data from an ancillary study of skeletal health within …
Read More »FDA Warning: Invokana Can Increase Risk of Bone Fracture
Bone mineral density at hip and lower spine may also decrease.
Read More »FDA Warns DPP-4 Inhibitors Could Cause Severe and Disabling Joint Pain
Risk warning, precaution added to labels of all drugs in this class… FDA warned recently that DPP-4 inhibitors could cause severe and disabling joint pain. The agency has added a new warning and precaution about this risk to the labels of all drugs in this class. If patients experience …
Read More »Type 1 Diabetes Linked to Increased Fractures
Lifelong condition may join list of various medical ailments for which type 1 patients are at an increased risk… A population-based cohort study published using data from The Health Improvement Network (THIN) was evaluated comparing records from 303,394 type 1 diabetes patients aged 0-89 years old with 303,872 random controls …
Read More »Can Papaya Reduce Risk of Diabetes?
Accessible fruit offers variety of health benefits…. Incorporating papaya into your diet can have many possible health benefits. Studies suggest that consuming papaya decreases the risk of obesity, diabetes, and heart disease as well as promotes healthy skin and hair, increases energy and decreases overall weight. Papaya is very accessible …
Read More »Dr. Janice Smiell: Biovance and the Future of Chronic Wound Care, Part 2
This week we have the second part of our two-art interview with Dr. Janice Smiell, CMO at Alliqua BioMedical, Inc. Dr. Smiell, and we delve a little deeper into the specifics of this new technology to heal chronic wounds using placental biomaterials. Steve Freed: With all the testing that is …
Read More »Genetic Variation May Determine Anti-Diabetic Drugs Response
Investigators are targeting individualized diabetes therapy using the genetic approach… Dr. Lazar and his team focused on a fat molecule called PPARγ, which is also the target for the thiazolidinedione (TZD) class of drugs. PPARγ binds to DNA and activates the expression of other genes. The researchers hypothesized that genetic …
Read More »GLP-1 Receptor Agonists Reduce Bone Loss During Weight Loss
A new study shows liraglutide mitigates the bone loss common with low calorie diets… Weight loss is frequently tied to reduced bone mass in adults who embark on a low calorie diet, putting them at increased risk of fractures following significant weight reduction. Furthermore, the reduction in bone mass does …
Read More »Diet That Mimics Fasting Appears to Slow Aging
Benefits demonstrated in mice and yeast; piloted in humans….
Read More »Practical Diabetes Care, 3rd Ed., Excerpt #25: Diabetic Neuropathy Part 5 of 5
David Levy, MD, FRCP Erectile dysfunction This is the commonest neuropathic complication: 20% of men have erectile dysfunction (ED) at diagnosis, increasing to 34% at 12 years (UKPDS). The prevalence in a newly diagnosed Kuwaiti population was 30%, and nearly 50% in a large survey of Canadians attending their primary-care physicians …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.